July 5th, 2022
•In line with the urgent need for screening for type 1 diabetes, celiac disease, and coronavirus disease 2019, we developed a high throughput 6-Plex electrochemiluminescence assay to simultaneously detect all four islet autoantibodies, tissue transglutaminase autoantibodies, and antibodies to the receptor binding domain of severe acute respiratory syndrome coronavirus 2.
Tags
Related Videos
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
A High-throughput Shigella-specific Bactericidal Assay
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved